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Abstract
Pontine noradrenergic neurones form part of a descending inhibitory system that influences spinal nociceptive processing. Weak or
absent descending inhibition is a common feature of chronic pain patients. We examined the extent to which the descending
noradrenergic system is tonically active, how control of spinal neuronal excitability is integrated into thalamic relays within sensory-
discriminative projection pathways, and how this inhibitory control is altered after nerve injury. In vivo electrophysiology was performed in
anaesthetised spinal nerve–ligated (SNL) and sham-operated rats to record from wide dynamic range neurones in the ventral
posterolateral thalamus (VPL). In sham rats, spinal block of a2-adrenoceptors with atipamezole resulted in enhanced stimulus-evoked
and spontaneous firing in the VPL, and produced conditioned place avoidance. However, in SNL rats, these conditioned avoidance
behaviours were absent. Furthermore, inhibitory control of evoked neuronal responses was lost, but spinal atipamezole markedly
increased spontaneous firing. Augmenting spinal noradrenergic tone in neuropathic rats with reboxetine, a selective noradrenergic
reuptake inhibitor, modestly reinstated inhibitory control of evoked responses in the VPL but had no effect on spontaneous firing. By
contrast, clonidine, an a2 agonist, inhibited both evoked and spontaneous firing, and exhibited increased potency in SNL rats compared
with sham controls. These data suggest descending noradrenergic inhibitory pathways are tonically active in sham rats. Moreover, in
neuropathic states, descending inhibitory control is diminished, but not completely absent, and distinguishes between spontaneous and
evoked neuronal activity. These observationsmay have implications for how analgesics targeting the noradrenergic systemprovide relief.
Keywords: In vivo electrophysiology, Ventral posterolateral thalamus, Conditioned place avoidance, Spinal nerve ligation,
Neuropathic pain, Descending inhibition, Noradrenaline, Noradrenaline reuptake inhibitor, a2-adrenoceptor
1. Introduction
Monoamine reuptake inhibitors are one of the commonly
prescribed treatments for neuropathic pain, yet across different
etiologies number needed to treat values only average around
6.4.17 Chronic pain conditions are frequently associated with
a loss of endogenous inhibition,68 and clearly, enhancement of
noradrenergic tone can be an effective treatment.17,79 Impor-
tantly, dividing patients into strata based on symptoms, which
may reflect distinct underlying pathophysiological mechanisms,
could improve patient outcomes.13,60,79
The importance of descending noradrenergic systems in pain
chronicity is highlighted by the development of conditioned pain
modulation (CPM) as a diagnostic tool as part of quantitative
sensory testing. Conditioned pain modulation, a paradigm
whereby heterotopic noxious stimulation reduces the pain
percept of a test stimulus, provides a readout of the integrity of
net endogenous inhibitory mechanisms. Patients with low CPM
have increased propensity to develop chronic pain after
surgery,78 and neuropathic patients with low CPM are more
likely to respond to treatment with duloxetine (a serotonin and
noradrenaline reuptake inhibitor [SNRI]) or tapentadol (a dual
m-opioid receptor agonist and noradrenaline reuptake inhibi-
tor).44,79 These clinical observations have been successfully
back-translated; diffuse noxious inhibitory controls, the analo-
gous process to CPM in animals, are mediated by noradrenaline
and are globally absent in neuropathic rats yet can be restored by
tapentadol and reboxetine (an NRI),3 and the ability to engage
descending inhibitory pathways influences severity of pain after
nerve injury in rats.12,75 Inhibition of spinal a2-adrenoceptors also
unmasks hypersensitivity in animals with no symptoms after
nerve ligation and contralateral hypersensitivity.12,28,75 These
studies suggest that noradrenergic pathways can act temporally
and spatially to restrict spinal hypersensitivity and support a loss
of inhibitory drive in neuropathic pain states.
Studies of descending modulation of pain typically use spinal
endpoints, either reflexive or electrophysiological. The former
assay is limited to examining withdrawal thresholds. The latter
affords the ability to examine modulation of suprathreshold input,
but the projection pathways of these neurones are rarely
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confirmed. Little is known about the impact of descending
brainstem control of spinal excitability on neuronal activity in
higher centres. To this end, we have studied the modulation of
ascending spinal activity and subsequent integration into the
ventral posterolateral thalamus (VPL), a key sensory discrimina-
tive relay. During neurosurgical procedures, microstimulation of
the ventralis caudalis can evoke thermal and mechanical
sensations.37,46 Furthermore, polymodal neurones within this
lateral thalamic pathway have the capacity to encode stimulus
intensity and have been characterised across species, including
humans.1,33,80 Unlike spinal neuronal responses after peripheral
nerve injury in rats,9,48,51 VPL wide dynamic range (WDR)
neurones exhibit higher rates of spontaneous firing and exagger-
ated responses to evoked stimulation.21,50,69 These electrophys-
iological recordings allow for a linear correlation of stimulus
intensity and response, and can provide a sensory neuronal
correlate of evoked hypersensitivity after injury.45 In an attempt to
define drug effects on affective state, we additionally perform
conditioned place avoidance (CPA) testing as this assay has the
advantage of providing insight into the rewarding or aversive
nature of pharmacological interventions.
2. Methods
2.1. Animals
Naı¨ve, sham-operated, and spinal nerve–ligated (SNL) (14-20
days after surgery) male Sprague-Dawley rats (250-350 g) were
used for behavioural and electrophysiological experiments
(Harlan, Indianapolis, IN and Biological Services, University
College London, United Kingdom, respectively). Animals were
group-housed (maximum of 4) on a conventional 12 hours:12
hours light-dark cycle; food and water were available ad libitum.
Temperature and humidity of holding rooms were closely
regulated. Electrophysiological and surgical procedures de-
scribed here were approved by the UK Home Office and adhered
to the Animals (Scientific Procedures) Act 1986. Behavioural and
surgical procedures were approved by the Institutional Animal
Care and Use Committee of the University of Arizona. All
experiments were designed in accordance with International
Association for the Study of Pain ethics guidelines.82
2.2. Spinal nerve ligation surgery
Spinal nerve ligation surgery was performed as previously
described.26 Rats (130-140 g) were maintained under 2% vol/
vol isoflurane anaesthesia delivered in a 3:2 ratio of nitrous oxide
and oxygen. Under aseptic conditions, a paraspinal incision was
made and the tail muscle excised. Part of the L5 transverse
process was removed to expose the left L5 and L6 spinal nerves,
which were then isolated with a glass nerve hook (Ski-Ry,
London, United Kingdom), and ligated with a nonabsorbable 6-
0 braided silk thread proximal to the formation of the sciatic nerve.
The surrounding skin and muscle was closed with absorbable 4-
0 sutures. Sham surgery was performed in an identical manner
omitting the nerve hook/ligation step. All rats groomed normally
and gained weight in the following days after surgery.
2.3. Intrathecal cannulation
For behavioural studies, intrathecal catheters were implanted 5 to
7 days before sham or spinal nerve ligation surgery as described
before.73,77 Rats were anaesthetised with intraperitoneal ket-
amine (80 mg/kg)/xylazine (12 mg/kg). After aseptic preparation,
the atlanto-occipital membrane was exposed and incised. A 7.5-
cm long PE-10 catheter was slowly inserted into the intrathecal
space through the membrane to the lumbar spinal cord. The
catheter was secured inside the muscle, and the skin was closed
with wound clips. The animals were single-housed after recovery.
Animals exhibiting signs of paralysis (,5%) were removed from
the study.
2.4. Paw withdrawal thresholds
Baseline thresholds were determined 1 day before sham or spinal
nerve ligation surgery. Rats were placed in isolation inside
chambers on a wire mesh floor and allowed to acclimatise. The
withdrawal threshold of the hind paw was measured in response
to probing of the plantar surface with a series of calibrated von
Frey filaments (Stoelting, Wood Dale, IL) in logarithmically spaced
increments ranging from 0.41 to 15 g. Each filament was applied
perpendicularly to the plantar surface of the left hind paw for 3
seconds; flinching, licking, shaking, or other directed behaviours
were considered positive responses. Withdrawal threshold was
determined by sequentially increasing or decreasing the stimulus
force (starting with the 2-g filament) using the “up-down” method
as previously described.8 Pharmacology was performed on
postoperative day 17; withdrawal thresholds were determined
before dosing and subsequently at 20, 40, and 60 minutes after
dosing. The experimenter was blinded to treatment group; rats
were randomised into groups (by an independent person), and
received either intrathecal vehicle (5-mL normal saline) or
atipamezole (20 mg/5 mL).
2.5. Conditioned place avoidance
A single-trial CPA protocol was performed as previously de-
scribed.32 On preconditioning day (day 13 after spinal nerve
ligation/sham surgery), rats were placed into the CPA boxes with
access to all chambers, and time spent in each chamber over 15
minutes was determined by an automated process. To assure no
chamber preference bias before conditioning, animals spending
more than 80% (720 seconds) or less than 20% (180 seconds) of
the total time in a chamber were eliminated from further testing.
Chamber pairings were counterbalanced between the control
and drug chambers. The following day, all rats received 5-mL
vehicle (normal saline) intrathecally and were immediately placed
into one randomly assigned conditioning chamber for 30 minutes
without access to the other chamber. Four hours later in the
afternoon, rats received intrathecal atipamezole (20 mg/5 mL)
paired with the opposite chamber for 30 minutes. On test day
(day 15 after spinal nerve ligation/sham surgery), 20 hours after
the afternoon pairing, rats were placed in the apparatus with
access to all chambers again, and their behaviour was recorded
for 15 minutes for automated analysis of chamber preference/
avoidance. The difference score was calculated by subtracting
the baseline time from the test time. The order of pairing with
morning saline and afternoon atipamezole avoided possible
effects of extended duration of action of the drug with learning
and is consistent with our previous methods.32
2.6. In vivo electrophysiology
Thalamic neuronal recordings were performed as previously
described.50 The experimenter was not blind to the injury or drug
administration. Animals were initially anaesthetisedwith 3.5% vol/
vol isoflurane delivered in 3:2 ratio of nitrous oxide and oxygen.
Once areflexic, a tracheotomy was performed and rats were
subsequently maintained on 1.5% vol/vol isoflurane for the
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remainder of the experiment. Rats were secured in a stereotaxic
frame, and after exposure of the skull, coordinates for the right
ventral posterolateral (VPL) thalamus (contralateral to injury) were
calculated in relation to bregma (2.28-mm caudal and 3.2-mm
lateral).70 A small craniotomy was performed with a high-speed
surgical microdrill. The muscle overlying the lumbar vertebrae
was removed, a partial laminectomy was performed to expose
the L4 to L6 lumbar region, and the overlying dura was removed.
Once haemostasis was achieved, the surrounding muscle was
coated in petroleum jelly to form a hydrophobic barrier to contain
the drug. Extracellular recordings were made from VPL thalamic
neurones with receptive fields on the glabrous skin of the left paw
hind toes (see Fig. 1 for stereotaxically determined recording
sites) using 127-mm diameter 2-MV parylene-coated tungsten
electrodes (A-M Systems, Sequim, WA). The receptive field was
stimulated using a range of natural stimuli (brush, von Frey
filaments—2, 8, 15, 26, and 60 g and heat—35, 42, 45, and
48˚C) applied over a period of 10 seconds per stimulus. The heat
stimulus was applied with a constant water jet onto the centre of
the receptive field. Acetone and ethyl chloride (100 mL) were
applied as an evaporative innocuous cooling and noxious
cooling stimulus, respectively,34 and responses quantified over
10 seconds after application. Evoked responses to room
temperature water (25˚C) were minimal, or frequently completely
absent, and subtracted from acetone-evoked and ethyl
chloride–evoked responses to control for any concomitant
mechanical stimulation during application. Stimuli were applied
starting with the lowest intensity stimulus with approximately 40
seconds between stimuli in the following order: brush, von Frey,
cold, and heat.
Animals were under anaesthesia for 4 to 6 hours. This included
obtaining baseline responses over the course of an hour and
determining drug effects over 2 hours. Baseline recordings were
stable over the first hour of recording; however, subsequent time-
dependent or order-dependent effects of drug dosing cannot be
ruled out over the remainder of the experiment. Baseline recordings
weremadewith 25-mL vehicle applied topically to the dorsal aspect
of the spinal cord (after aspiration of any cerebrospinal fluid), hence
all observed effects can be attributed to drug actions. After 3
baseline trials (stimuli applied in the order described above with 5
minutes between each set of trials, data were averaged to give
control values), the vehicle was removed, and 50-mg and 100-mg
atipamezole (Sigma, Gillingham, United Kingdom), or 10-mg and
50-mg reboxetine mesylate (Tocris, Abingdon, United Kingdom)
were cumulatively applied to the spinal cord in a volume of 25 mL
(vehicle: 97%normal saline, 2%cremophor, 1%dimethylsulfoxide),
and neuronal responses were characterised 20 and 40 minutes
after dosing. For clonidine studies, 50- and 100-mg clonidine
hydrochloride (Sigma)were applied to the cord in a volumeof 25mL
(vehicle: normal saline), and neuronal responses were character-
ised 10 and 30 minutes after dosing; time point of peak change
from baseline is plotted. The second dose was applied approxi-
mately 50 to 60 minutes after aspiration of the first dose; excess
drug was washed from the cord with 25-mL vehicle (applied for 2-3
minutes). Drug doses were guided by previous studies,3,7,27,54,64
and their effects were tested in a pilot study.
Data were captured and analysed by a CED1401 interface
coupled to a computer with Spike2 v6 software (Cambridge
Electronic Design, Cambridge, United Kingdom) with rate functions.
The signal was amplified (36000), bandpass filtered (low-/high-
frequency cutoff 1.5/2 kHz), and digitised at rate of 20 kHz. Spike
sorting was performed post hoc with Spike2 using fast Fourier
transform followed by 3-dimensional principal component analysis
of waveform feature measurements for multiunit discrimination.
Neuroneswere recorded from one site per rat; 1 to 3 neuroneswere
characterised at each site. Stimulus-evoked neuronal responses
were determined by subtracting total spontaneous neuronal activity
in the 10-second period immediately preceding stimulation.
Spontaneous firing of individual neurones (number of spikes per
second) is expressed as the mean of these 10-second periods.
Burst firing (number of bursts per second) was determined over
a period of 60 seconds in the absence of stimulation as previously
described.23 Burst parameters were maximum initial interval
signifying burst onset (6 ms), longest interspike interval allowed
within burst (9 ms), and minimum number of events in a burst (2).
2.7. Statistics
Statistical analyses were performed using SPSS v25 (IBM,
Armonk, NY). Heat and mechanical coding of neurones were
compared with a 2-way repeated-measures (RM) analysis of
variance (ANOVA), followed by a Bonferroni post hoc test for
paired comparisons. Cold, brush, and spontaneous/burst firing
were compared with a 1-way RM ANOVA, followed by
a Bonferroni post hoc test for paired comparisons. Conditioned
place avoidance measures were compared with a 2-way RM
ANOVA, followed by a Bonferroni post hoc test for paired
comparisons, whereas difference scores were compared with an
unpaired Student t test. Where appropriate, sphericity was tested
using Mauchly test; the Greenhouse-Geisser correction was
applied if violated. Paw withdrawal time courses were compared
with the Friedman test, followed by a Wilcoxon post hoc and
Figure 1. Recording sites within the ventral posterolateral thalamus from 13 sham and 20 neuropathic rats. Filled circles (d) represent sham, and open circles (s)
represent spinal nerve–ligated (SNL) rat experiments.
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Bonferroni correction for paired comparisons. Minimum group
sizes were determined by a priori calculations (a 0.05, 12 b 0.8).
All data represent mean 6 95% confidence interval. *P , 0.05,
**P , 0.01, ***P , 0.001.
3. Results
3.1. Spinal a2-adrenoceptor inhibition has no effect on
stimulus-evoked withdrawal responses in sham and spinal
nerve–ligated rats
To determine the extent of any descending inhibitory control of
hind paw withdrawal responses, the a2-adrenoceptor antagonist
atipamezole (20mg/5mL) was delivered intrathecally to sham and
SNL rats, and withdrawal thresholds to punctate mechanical
stimulation quantified. In sham-operated rats, withdrawal thresh-
olds after surgery (day 17) were comparable with baseline
responses (Wilcoxon test, P5 1.00), whereas SNL rats exhibited
mechanical hypersensitivity after peripheral nerve injury (Wilcoxon
test, P 5 0.00098) (Fig. 2A). Neither intrathecal vehicle nor
atipamezole altered withdrawal thresholds in sham-operated rats
(Friedman test, vehicle: P 5 1.00, atipamezole: P 5 0.392).
Similarly, in SNL rats neither vehicle nor atipamezole had any
overall effect on established mechanical hypersensitivity (Fried-
man test, vehicle: P5 0.478, atipamezole: P5 0.069) (Fig. 2B).
3.2. Wide dynamic range neurones in the VPL exhibit
hyperexcitability in spinal nerve–ligated rats
Behavioural observations were extended to include awider range
of modalities and intensities by characterising sensory neuronal
processing in the VPL. Wide dynamic range neurones were
identified on the basis of responses to brush, noxious punctate
mechanical stimulation, and noxious thermal stimulation of the
receptive field. After obtaining stable baseline responses,
pharmacological studies were performed. A total of 49 neurones
were characterised; Table 1 summarises predrug baseline
responses to evoked stimulation. Wide dynamic range neurones
in SNL rats exhibited greater stimulus-evoked responses, and
higher rates of spontaneous and burst firing consistent with our
previous observations.50 In a separate study, this elevated
spontaneous firing rate was inhibited by spinal and intraplantar
lidocaine in SNL rats (data not shown) implying ongoing activity in
sensory projection pathways, although we cannot conclude
whether this represents noxious activity.
3.3. Spinal a2-adrenoceptor inhibition reveals tonic
noradrenergic inhibitory tone in naı¨ve/sham rats
After application of 50- and 100-mg atipamezole to the spinal cord,
inhibition ofa2-adrenoceptors increased evoked thalamic neuronal
responses to low intensity (8 g) and to intensities that may reach
and then exceed noxious levels (15, 26, and 60 g) of punctate
mechanical stimulation (2-way RM ANOVA P5 0.000096, F2,205
15.21) (Fig. 3A). In addition, heat-evoked responses were
increased at noxious intensities of stimulation (2-way RM ANOVA
P 5 0.019, F2,20 5 4.899) (Fig. 3B). Acetone and ethyl chloride
were applied as innocuous and noxious evaporative cooling
stimuli, respectively. Neuronal responses to innocuous cooling
were unaffected by spinal atipamezole (1-way RM ANOVA P 5
0.144, F1.28,12.79 5 2.383); however, noxious cold-evoked
responses were facilitated (1-way RM ANOVA P 5 0.016, F2,20
5 5.096) (Fig. 3C). Dynamic brush-evoked responses were also
enhancedafter dosing (1-wayRMANOVAP50.007, F2,2056.49)
(Fig. 3D). Spontaneous activity increased in 8/11 units within 5 to
10 minutes of drug application (1-way RM ANOVA P 5 0.028,
F1.13,11.30 5 6.079) (Fig. 3E), and this increased activity was
sustained for the duration of the experiment. However, there was
no overall effect on the burst rate (1-way RM ANOVA P 5 0.069,
F1.14,11.375 3.926) (Fig. 3F). Effect sizes in naı¨ve (n5 4 neurones
from 3 rats) and sham animals (n 5 7 neurones 5 rats) were
comparable and thus were pooled for analysis.
3.4. Spinala2-adrenoceptor inhibition reveals a selective loss
of descending inhibitory control of evoked neuronal
responses in spinal nerve–ligated rats
Unlike in sham-operated rats, 50- and 100-mg atipamezole had
no effect on punctate mechanical (2-way RM ANOVA P5 0.432,
F2,205 0.876) (Fig. 4A), heat (2-way RMANOVA P5 0.848, F2,20
5 0.167) (Fig. 4B), cooling (acetone: 1-way RM ANOVA P 5
0.226, F2,20 5 1.604; ethyl chloride: 1-way RM ANOVA P 5
0.370, F2,20 5 1.047) (Fig. 4C), and brush-evoked neuronal
responses in the VPL of SNL rats (1-way RM ANOVA P5 0.858,
F2,20 5 0.154) (Fig. 4D). Surprisingly, in contrast to the lack of
effect on evoked responses, spontaneous activity (1-way RM
ANOVA P 5 0.0039, F1.04,10.39 5 13.415) (Fig. 4E) and burst
Figure 2. Spinal a2-adrenoceptor inhibition does not alter withdrawal
thresholds in sham and SNL rats. Mechanically evoked withdrawal thresholds
in sham (n 5 29) and SNL rats (n 5 14) before surgery and on postoperative
day 17 (A). Paw withdrawal thresholds before and after intrathecal delivery of
either vehicle (sham: n 5 13, SNL n 5 6) or atipamezole (sham: n 5 16, SNL
n 5 8) (B). Data represent mean 6 95% CI. ***P , 0.001. CI, confidence
interval; i.t., intrathecal; SNL, spinal nerve–ligated.
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firing (1-way RM ANOVA P 5 0.00079, F2,20 5 10.428) (Fig. 4F)
substantially increased after spinal delivery of atipamezole.
3.5. Spinal a2-adrenoceptor inhibition induces conditioned
place avoidance in sham but not spinal nerve–ligated rats
In light of the aforementioned observations, we next examined
whether inhibiting spinal a2-adrenoceptors produced avoidance
learning behaviours in sham and SNL rats. The time spent in
atipamezole (20 mg/5 mL) and vehicle-paired chambers during
preconditioning trials were comparable across groups. After
conditioning, most sham-operated animals (7/10) displayed clear
avoidance of the atipamezole-paired chamber, and a corre-
sponding increase in the time spent in the vehicle-paired
chamber was observed (2-way RM ANOVA P 5 0.0033, F1,9 5
15.599) (Fig. 5A). By contrast, SNL rats displayed no preference
for the vehicle- or atipamezole-paired chamber after a single
conditioning trial (2-way RM ANOVA P 5 0.502, F1,6 5 0.511)
(Fig. 5B) or after 2 conditioning trials (data not shown). The
difference scores (atipamezole-paired chamber) further illustrate
the larger effect size in sham rats compared with SNL (unpaired
Student’s t test, t 5 2.54, df 5 15, P 5 0.0227) (Fig. 5C).
3.6. Activation of spinala2-adrenoceptors attenuates evoked
and spontaneous firing in the VPL in sham and spinal
nerve–ligated rats
Spinal clonidine (50 and 100 mg), an a2-adrenoceptor agonist,
dose dependently inhibited evoked and spontaneous thalamic
neuronal firing. In sham rats, responses to punctate mechanical
(2-way RM ANOVA P5 0.000005, F2,145 32.636) (Fig. 6A) and
heat stimuli (2-way RM ANOVA P5 0.00265, F2,145 9.342) (Fig.
6B) were reduced across intensities of stimulation. Responses to
innocuous cooling were unaffected, although noxious cooling-
evoked responses were reduced by clonidine (acetone: 1-way
RM ANOVA P 5 0.163, F1.07,7.49 5 2.399; ethyl chloride: 1-way
RMANOVA P5 0.0109, F2,145 6.356) (Fig. 6C). We foundweak
evidence for an overall decrease in brush-evoked firing (1-way
RM ANOVA P5 0.0411, F2,145 4.044, paired comparisons P.
0.05) (Fig. 6D). Low rates of spontaneous firing were observed
and were only inhibited at the highest dose tested (1-way RM
ANOVA P 5 0.0171, F1.21,8.49 5 8.12) (Fig. 6E). Likewise, the
levels of burst firingwereminimal butwere not altered by clonidine
(1-way RM ANOVA P 5 0.115, F2,14 5 2.529) (Fig. 6F).
In SNL rats, spinal clonidine exhibited enhanced inhibitory
effects at both doses tested, particularly onmechanical and heat-
evoked responses (Figs. 7A–F and Supplementary Table 1;
available online at http://links.lww.com/PAIN/A596). Neuronal
responses to punctate mechanical (2-way RM ANOVA P 5
0.000003, F2,14 5 36.573) (Fig. 7A) and heat stimuli (2-way RM
ANOVAP5 0.000046, F2,145 22.11) (Fig. 7B) were substantially
decreased compared with baseline, again across intensities of
stimulation. There was no overall effect on responses to
innocuous cooling; however, noxious cold evoked markedly
fewer spikes (acetone: 1-way RM ANOVA P 5 0.092, F2,14 5
2.844; ethyl chloride: 1-way RM ANOVA P 5 0.00786, F1.05,7.37
5 12.79) (Fig. 7C). Compared with sham rats, a greater inhibitory
effect on brush-evoked responses was also notable (1-way RM
ANOVA P 5 0.0173, F2,14 5 5.5) (Fig. 7D). In addition, clonidine
reduced levels of spontaneous firing at both doses (1-way RM
ANOVA P 5 0.0131, F1.06,7.39 5 10.337) (Fig. 7E), although the
burst rate was only lower at the highest dose tested (1-way RM
ANOVA P 5 0.0436, F2,14 5 3.951) (Fig. 7F).
3.7. Augmenting spinal noradrenergic tone with reboxetine
modestly restores inhibitory control of evoked responses in
spinal nerve–ligated rats
Reboxetine (10 and 50 mg), administered spinally to SNL rats,
reduced mechanically evoked neuronal responses in the VPL
with greater effect on lower intensity stimuli compared with
noxious stimuli (2-way RM ANOVA P 5 0.0372, F2,20 5 3.899)
Table 1
Baseline characterisations of wide dynamic range neurones in the ventral posterolateral thalamus of naı¨ve/sham and spinal
nerve–ligated (SNL) rats.
Sham n 5 19 SNL n 5 30
Brush 351 6 40.45 367 6 26.20 Unpaired t test P 5 0.742
2 g 44 6 10.20 48 6 8.70 2-way ANOVA, F1,230 5 16.51, P 5 0.00007
8 g 194 6 27.84 275 6 22.17*
15 g 304 6 36.30 422 6 38.26*
26 g 411 6 45.72 574 6 43.34*
60 g 549 6 53.98 731 6 54.52*
35˚C 298 6 43.87 296 6 28.48 2-way ANOVA, F1,188 5 3.97, P 5 0.048
42˚C 393 6 56.13 381 6 38.44
45˚C 455 6 64.21 431 6 40.19
48˚C 522 6 122.23 758 6 55.17*
Acetone 29 6 6.48 52 6 14.15 Unpaired t test P 5 0.239
Ethyl chloride 123 6 19.20 370 6 47.30‡ Unpaired t test P 5 0.00003
Spontaneous firing (spikes/s) 5.45 6 0.90 22.73 6 3.76‡ Unpaired t test P 5 0.00012
Burst rate (bursts/s) 0.47 6 0.20 3.87 6 0.97† Unpaired t test P 5 0.002
Unless otherwise specified, data represent mean total evoked spikes 6 95% CI.
* P , 0.05.
† P , 0.01.
‡ P , 0.001.
ANOVA, analysis of variance.
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(Fig. 8A). Overall, heat-evoked responses were unaffected (2-
way RM ANOVA P 5 0.409, F2,20 5 0.936) (Fig. 8B), although
responses evoked by noxious cooling were inhibited (acetone: 1-
way RM ANOVA P 5 0.842, F1.2,12.01 5 0.68; ethyl chloride: 1-
way RM ANOVA P 5 0.0346, F1.23,12.31 5 5.249) (Fig. 8C). In
addition, there was weak evidence for a decrease in dynamic
brush-evoked responses at the highest dose tested (1-way RM
ANOVA P 5 0.0276, F2,20 5 4.317, paired comparisons P .
0.05) (Fig. 8D). In marked contrast to the effects of spinal
clonidine, reboxetine affected neither spontaneous activity (1-
way RM ANOVA P5 0.187, F1.19,11.865 1.967) (Fig. 8E) nor the
burst rate (Fig. 8F) (1-way RM ANOVA P5 0.666, F2,205 0.415).
4. Discussion
In this article, we describe how descending noradrenergic
inhibition of spinal excitability impacts sensory coding in the
ventral posterior thalamus. These data support that distinct
mechanisms mediate inhibition of evoked and spontaneous
neuronal activity after nerve injury. Furthermore, this distinction in
inhibitory control has consequences for the actions of analgesics
targeted at enhancing endogenous inhibitory tone in neuropathic
conditions. To our knowledge, we also demonstrate for the first
time that negating spinal noradrenergic activity through a2-
adrenoceptors in sham rats, ie, in the absence of neuropathic
injury, produces a negative affective state.
Noradrenaline in the spinal cord is derived from nuclei within
the dorsolateral pontine tegmentum.6 NK1-positive projection
neurones of the superficial dorsal horn are the origin of a spino-
bulbospinal circuit, which through the parabrachial and dorsal
raphe nuclei can activate descending facilitation.58,67 Ablation of
these neurones reveals that this population also drives descend-
ing inhibition through a pontospinal loop;55 however, the resultant
net decrease in spinal neuronal excitability indicates facilitation
Figure 3. Inhibiting spinal a2-adrenoceptors increases stimulus-evoked and spontaneous firing in the VPL of naı¨ve/sham rats. Wide dynamic range (WDR)
neuronal responses to punctate mechanical (A), heat (B), cold (C), dynamic brush (D) stimuli, and spontaneous (E) and burst firing rates (F), before and after spinal
administration of atipamezole. Histogram and event mark traces represent typical single-unit responses. Data represent mean6 95%CI, n5 11 neurones from 8
rats. *Difference between baseline and 50-mg atipamezole, †difference between baseline and 100-mg atipamezole, *P , 0.05, **P , 0.01. Ac, acetone; CI,
confidence interval; Ec, ethyl chloride.
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predominates. Significant engagement of noradrenergic inhibi-
tory pathways is apparent during extended periods of nociceptive
activity,20,39 acutely after an inflammatory insult or nerve in-
jury,7,28 and in response to pruritogens.18,19 By contrast, there is
a paucity of compelling evidence for the existence of tonic
noradrenergic control of spinal excitability. Contradictory findings
propose that either minimal/no basal activity exists within
descending noradrenergic pathways,25,29,38,41,71 or that, these
spinally directed projections tonically suppress reflex responses
and spinal neuronal responses to low-intensity stimuli.24,54,55,59
We provide evidence of tonic descending inhibitory drive,
which exerts inhibitory effects across sensory modalities and
intensities of stimulation through a2-adrenoceptors, whereas in
neuropathic rats, noradrenergic inhibition is partially diminished
and discriminates between spontaneous and evoked activity.
Previously, spinally administered atipamezole was demonstrated
to increase spontaneous and evoked activity of dorsal horn
lamina V/VI WDR neurones in sham rats,54 and corresponds with
the changes in neuronal excitability observed here in the VPL.
However, in SNL rats, atipamezole had no effect on either evoked
or spontaneous spinal neuronal activity.54 It has been reported
that dorsal horn neurones without receptive fields can exhibit high
levels of spontaneous firing after peripheral nerve injury.11,65
Likewise, after amputation or in deafferentation pain, thalamic
neurones without receptive fields but within the region of
representation of the injury can exhibit high rates of burst and
spontaneous firing.35,36,57,72We hypothesise that after peripheral
nerve injury, ectopic neuronal events in denervated regions of the
dorsal horn are actively supressed through a postsynaptic a2-
adrenoceptor–dependent mechanism and disinhibition by spinal
atipamezole results in increased spontaneous activity in the VPL.
By contrast, in regions of the dorsal horn where peripheral
innervation is conserved despite nerve injury, descending
noradrenergic inhibitory influences seem minimal as is evident
by the lack of change in evoked neuronal responses in the VPL
and dorsal horn after spinal atipamezole application (Fig. 9). Our
data suggest that, akin to data on diffuse noxious inhibitory
controls,3 the descending noradrenergic pathway is less active
Figure 4. Inhibiting spinal a2-adrenoceptors selectively increases spontaneous firing in the VPL of SNL rats. Wide dynamic range (WDR) neuronal responses to
punctate mechanical (A), heat (B), cold (C), dynamic brush (D) stimuli, and spontaneous (E) and burst firing rate (F), before and after spinal administration of
atipamezole. Histogram and event mark traces represent typical single-unit responses. Data represent mean6 95%CI, n5 11 neurones from 7 rats. *Difference
between baseline and 50-mg atipamezole, †difference between baseline and 100-mg atipamezole, *P , 0.05, **P , 0.01. CI, confidence interval; SNL, spinal
nerve–ligated.
Figure 5. Inhibiting spinal a2-adrenoceptors produces avoidance learning behaviour in sham but not SNL rats. Time spent in respective drug-paired chambers
before and after conditioning with vehicle and atipamezole in sham rats (n5 10) (A). Time spent in respective drug-paired chambers before and after conditioning
with vehicle and atipamezole in SNL rats (n5 7) (B). Difference score (atipamezole-paired chamber) for SNL and sham rats (C). Data represent mean6 95%CI. *P
, 0.05, **P , 0.01. CI, confidence interval; SNL, spinal nerve–ligated.
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after neuropathy but remains intact. The conserved integrity of
this pathway is further illustrated by the selective activation of
spinally projecting locus coeruleus neurones because antinoci-
ceptive effects can still be produced in neuropathic states.25
Both animal and human data suggest that sensory and affective
dimensions of pain are partially separable and implicate the anterior
cingulate cortex in mediating the aversive qualities of pain.30,53,56
After sham surgery, conditioned avoidance behaviours were
precipitated by block of spinal a2-adrenoceptors, which would
be consistent with disinhibition within medial projection pathways
converging onto the anterior cingulate cortex. The concurrent
increase in spontaneous activity within the STT-VP-S1-2 pathway
may reflect the sensory component, although it is unclear whether
this represents noxious inputs.By contrast, intrathecal atipamezole
failed to induce CPA in SNL rats. As neuropathic animals
experience an ongoing aversive pain state, an increase in
spontaneous firing within lateral but not medial pathways could
underlie a failure to drive avoidance learning behaviours because
sensory but not affective processing is enhanced by inhibition of
spinal a2-adrenoceptors. The effects of atipamezole onwithdrawal
thresholds are comparable with our previous observations with
intrathecal yohimbine.12 The disparity between the effect of
intrathecal atipamezole on reflex withdrawal responses and
evoked neuronal correlates likely reflects differences in processing
mechanisms. Spinallymediated reflex withdrawals are surmised to
represent sensory processing, but it is difficult to dissociate the
sensory and motor components. In sham rats, the observed
leftward shift in the stimulus-response relationship of WDR
neurones was perhaps not sufficient to elicit enhanced motor
responses. Consequently, the sensorimotor endpoints should be
interpreted cautiously, and the neuronal measures may provide
a more sensitive readout of subtle changes in sensory processing.
Figure 6. Activating spinal a2-adrenoceptors reduces stimulus-evoked and spontaneous firing in the VPL of sham rats. Wide dynamic range (WDR) neuronal
responses to punctate mechanical (A), heat (B), cold (C), dynamic brush (D) stimuli, and spontaneous (E) and burst firing rate (F), before and after spinal
administration of clonidine. Histogram and event mark traces represent typical single-unit responses. Data represent mean6 95%CI, n5 8 neurones from 5 rats.
*Difference between baseline and 50-mg clonidine, †difference between baseline and 100-mg clonidine, *P , 0.05, **P , 0.01, ***P , 0.001. Ac, acetone; Ec,
ethyl chloride; CI, confidence interval.
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We further examined the effects of clinically used approaches
to augmenting spinal noradrenergic tone: enhancing synaptic
noradrenaline and directly activating a2-adrenoceptors. Dimin-
ished inhibitory control of evoked responses in neuropathic
animals was weakly restored by spinal reboxetine in a modality-
selective manner, but spontaneous activity was unaffected. The
latter observation may reflect a “ceiling effect” as blocking
reuptake of noradrenaline fails to enhance the high levels of
basal activity within this pathway, which were revealed by
atipamezole (Fig. 9). The modality-selective inhibition of mechan-
ical and cold-evoked responses and weaker effects on heat-
evoked responses implies preferential engagement of inhibitory
receptors on subsets of primary afferent terminals. In the dorsal
horn, these are predominantly a2A receptors that colocalise with
substance P,62 and a2A receptors are differentially upregulated in
fibre subtypes after injury.5 Altered receptor density could in turn
affect the ability of noradrenaline to inhibit Ad- and C-fibre–
evoked transmission.31 It is also possible that these modest
inhibitory effects are influenced by descending serotonergic
facilitatory drive because, in neuropathic states, increased spinal
5-HT3 receptor activation can mask low levels of residual
noradrenergic inhibition.3
Spinal clonidine has been used clinically as an adjunct or in
isolation for amelioration of evoked and ongoing pain,16 and can
be beneficial in patients with refractory cancer pain particularly
those with neuropathic characteristics.15 In sham and SNL rats,
clonidine exhibited inhibitory effects across sensory modalities
and intensity of stimulus, and would be consistent with a pre-
dominantly postsynaptic inhibitory effect in the dorsal horn. Both
spinally applied noradrenaline and clonidine induce postsynaptic
Figure 7. Activating spinal a2-adrenoceptors reduces stimulus-evoked and spontaneous firing in the VPL of SNL rats. Wide dynamic range (WDR) neuronal
responses to punctate mechanical (A), heat (B), cold (C), dynamic brush (D) stimuli, and spontaneous (E) and burst firing rate (F), before and after spinal
administration of clonidine. Histogram and event mark traces represent typical single-unit responses. Data represent mean6 95%CI, n5 8 neurones from 6 rats.
*Difference between baseline and 50-mg clonidine, †difference between baseline and 100-mg clonidine, *P , 0.05, **P , 0.01, ***P , 0.001. Ac, acetone; Ec,
ethyl chloride; CI, confidence interval; SNL, spinal nerve–ligated.
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outward currents in superficial dorsal horn neurones in vivo, in
addition to decreasing the frequency of pinch-evoked excitatory
postsynaptic currents.61 Presynaptic inhibitory effects can be
mediated through a2A receptors on primary afferents,
62 a2C
receptors expressed by excitatory interneurones,47 and at higher
doses, a1 receptors on inhibitory interneurones are potentially
activated.2 The increased potency of a2-adrenoceptor agonists
in neuropathic states implies plasticity within spinal circuits after
an injury.66,76 In particular, this could relate to increases in a2-
adrenoceptor density and enhanced receptor coupling to G-
proteins to compensate for a loss of inhibitory tone due to
hypoactivity in the descending pathway.4,5,63 Intrathecal cloni-
dine alleviated ongoing pain and concomitantly activated reward
pathways in SNL, but not sham-operated rats,32,40,74 and
similarly, intrathecal reboxetine produced conditioned place
preference in amanner dependent on pathophysiological state.27
Speculatively, intrathecal clonidine and reboxetine may have
distinct actions on sensory and affective processing. However,
a potential confound of this study is the rapid absorption of
clonidine; inhibitory effects could be attributed to supraspinal
mechanisms as direct actions within the locus coeruleus will
impact both ascending and descending modulation of sensory
transmission.22,42,81
In addition to proving a readout of “bottom-up” processing
mechanisms, thalamic relay neurones are subjected to “top-
down” processing. Corticofugal outputs can modulate sensory
transmission,43 and thalamo-cortical neurones send collaterals
to the thalamic reticular nucleus, which in turn exerts GABAergic
inhibitory influences on the thalamus.52 Burst propensity can be
regulated by tonic GABAA receptor activation,
10 and the changes
in burst firing rates observed in this study may largely be
determined by these circuits as a consequence of altered
Figure 8. Blocking spinal noradrenaline reuptake reduces stimulus-evoked firing in the VPL of SNL rats. Wide dynamic range (WDR) neuronal responses to
punctate mechanical (A), heat (B), cold (C), dynamic brush (D) stimuli, and spontaneous (E) and burst firing rate (F), before and after spinal administration of
reboxetine. Histogram and event mark traces represent typical single-unit responses. Data represent mean 6 95% CI, n5 11 neurones from 7 rats. *Difference
between baseline and 10-mg reboxetine, †difference between baseline and 50-mg reboxetine, *P , 0.05, **P , 0.01. Ac, acetone; CI, confidence interval; Ec,
ethyl chloride; SNL, spinal nerve–ligated.
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ascending spinal output. In addition, noradrenergic projections
from the midbrain can influence neuronal excitability. In slice
preparations, noradrenalinemediates a switch from burst to tonic
firing patterns.49 This pathway provides a putative mechanism by
which the state of alertness or arousal can influence sensory
transmission.14 It is also possible that inhibition of the pontospinal
pathway leads to an imbalance in themultilevel modulation by the
noradrenergic system and alters ascending sensory signalling.
In conclusion, these data may have implications for the clinical
approach of enhancing endogenous inhibitory activity. For those
patients with small and/or large fibre neuropathy, where deaf-
ferentation of spinal neurones is likely, a significant component of
ongoing pain may be driven by ectopically firing spinal neurones.
Overall, patient outcomes for SNRIs could remain poor given the
inability of spinal reboxetine to supress aberrant spontaneous
neuronal activity in this model. Interestingly, inefficient CPM in
diabetic neuropathy patients correlated with relative preservation
of large afferents and advocates continued sensory profiling on
this basis because there is an increased likelihood of benefit from
SNRIs in this patient group.79 Subtype-specific a2-adrenoceptor
agonists could be the focus of future investigations to assess
whether spinal and supraspinal mechanisms can be dissociated.
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